Gastineau DA, Gertz MA, Daniels TM, et al. Inhibitor of the Thrombin Time
in Systemic Amyloidosis: A Common Coagulation Abnormality. Blood. Červen 1991, roč. 77, čís. 12, s. 2637-2640. Dostupné online. PMID1904284.
clinchem.org
Flanders MM, Crist R, Rodgers GM. Comparison of five thrombin time reagents. Clin. Chem.. January 2003, roč. 49, čís. 1, s. 169–72. Dostupné online. PMID12507975.[nedostupný zdroj]
nih.gov
ncbi.nlm.nih.gov
Flanders MM, Crist R, Rodgers GM. Comparison of five thrombin time reagents. Clin. Chem.. January 2003, roč. 49, čís. 1, s. 169–72. Dostupné online. PMID12507975.[nedostupný zdroj]
Carr ME Jr, Gabriel DA. Hyperfibrinogenemia as a cause of prolonged thrombin clotting time. South Med J.. Květen 1986, roč. 79, čís. 5, s. 563-570. PMID3704722.
Gastineau DA, Gertz MA, Daniels TM, et al. Inhibitor of the Thrombin Time
in Systemic Amyloidosis: A Common Coagulation Abnormality. Blood. Červen 1991, roč. 77, čís. 12, s. 2637-2640. Dostupné online. PMID1904284.
Alexander Haliassosa, Helen Melita-Manolis, Despina Aggelaki, Despina Tassi and George Terzoglou. Use of Anti-Xa Activity as a Marker for Heparin-Induced Bleeding in Patients with APTT >180 s. Clinical Chemistry. Září 1997, roč. 43, čís. 9, s. 1781-1782. PMID9299975.